Eli Lilly’s Obesity Drug Zepbound Reduces Sleep Apnea in Late-Stage Studies
The injection lowered obstructive sleep apnea severity by up to nearly two-thirds in obese adults, with and without PAP therapy, in two phase 3 trials.
Tag: pharmaceuticals
All
Latest
All
Latest
Popular Obesity Drugs Linked to Aspiration Pneumonia Following Endoscopy
New research warns individuals scheduled for medical procedures to halt popular weight loss drugs like Ozempic and Wegovy prior to prevent aspiration pneumonia, a risk associated with these medications.
All
Latest
AstraZeneca Sets $35 Monthly Cap on Inhaler Costs
Starting June 1, eligible patients will pay no more than $35 per month for all AstraZeneca US inhaled respiratory medicines.
$9M NIH Grant Fuels Progress of Novel Smoking Cessation Drug
Funding awarded to scientists at Camino Pharma, Sanford Burnham Prebys, and UC San Diego will expand the nonclinical studies to support a phase 2 clinical evaluation of SBP-9330.
Read More
Calluna Pharma Launches with €75M for Inflammatory and Fibrotic Disease Therapies
The new company, formed through a merger between Oxitope and Arxx, has a pipeline of selective antibodies that target inflammatory and fibrotic indications, including several first-in-class clinical candidates.
Read More
FDA-approved Anti-inflammatory Rescue Inhaler for Asthma Now Available
The inhaler contains a short-acting beta2-agonist to help relax the smooth muscles of the airways and an inhaled corticosteroid to help decrease inflammation in the lungs, treating both symptoms and inflammation.
Read More
Stapled Lipopeptide Protects against SARS-CoV-2 Infection
A stapled lipopeptide can successfully protect against infection by SARS-CoV-2, the virus that causes COVID-19.
Read More
AAFA Applauds Senate Investigation into Asthma Inhaler Pricing
AAFA says the investigation opens an opportunity to address what patients report as the primary reason why people don’t adhere to their asthma treatment: the cost of prescribed asthma medication.
Read More
Gabapentinoids May Cause Severe COPD Exacerbation
Researchers say the study supports warnings from regulatory agencies and highlights the importance of considering this potential risk when prescribing gabapentin and pregabalin to patients with COPD.
Read More
Singulair Black Box Warning Did Little to Alert Patients to Potential Side Effects
An article published by the New York Times outlines how an FDA black box warning for the asthma drug Singulair (montelukast) did little to alert patients to its potential mental health side effects or to dissuade physicians from prescribing it.
Read More
Congress to Investigate High Cost of Asthma Inhalers
A Congressional committee led by Senator Bernie Sanders are demanding answers from pharmaceutical companies on the high costs of asthma inhalers, according to a report by The Hill.
Read More
Yupelri Not Superior to Spiriva in Phase 4 Trial
Theravance Biopharma’s COPD treatment Yupelri was not superior to Boehringer Ingelheim’s Spiriva Handihaler, according to results from a phase 4 study reported by Theravance.
Read More
Preexisting Conditions May Elevate Heart Disorder Risk Post COVID-19 Vaccine
Cedars-Sinai investigators suggest it may be helpful to keep an eye on patients with underlying health issues after COVID-19 vaccination to monitor for post-vaccine POTS, a condition that causes an abnormal increase in heart rate after standing or sitting up.
Read More
Full RSV Vaccination Could Cut Senior Hospitalizations by 91.7%
Respiratory syncytial virus vaccines recently approved for people 60 and older would dramatically reduce the disease’s burden of illness and death if they were widely adopted like annual influenza vaccines, a Yale University study finds.
Read More
Beyfortus Approved in China to Prevent RSV Infants
AstraZeneca and Sanofi’s Beyfortus (nirsevimab), a long-acting monoclonal antibody, has been approved in China for the prevention of respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) in neonates and infants entering or during their first RSV season.
Read More